An antibody–drug conjugate for endometrioid carcinoma based on the expression of cell adhesion molecule 1
Cell adhesion molecule 1 (CADM1), an immunoglobulin superfamily member, is expressed in endometrial glandular cells highly during the proliferative phase but lowly during the secretory phase. Previously, a CADM1–targeting antibody–drug conjugate (ADC) was generated, in which a humanized anti-CADM1 e...
Saved in:
| Main Authors: | Man Hagiyama, Azusa Yoneshige, Tomoyuki Otani, Akihiro Wada, Fuka Takeuchi, Yuji Shoya, Takao Inoue, Akihiko Ito |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Molecular & Cellular Oncology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/23723556.2024.2399379 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of cyclin D1 on endometrial hyperplasia and endometrioid endometrial carcinoma
by: Sudha M, et al.
Published: (2025-06-01) -
Modern approaches to the diagnosis of endometrial hyperplasia
by: M. M. Damirov, et al.
Published: (2025-02-01) -
Markers of proliferation and angiogenesis in endometrial hyperplastic processes combined with uterine fibroids
by: Yu. Ya. Krut, et al.
Published: (2020-04-01) -
Results of surgical treatment of atypical endometrial hyperplasia
by: O. A. Gornykh, et al.
Published: (2014-07-01) -
Diagnosis of endometrial hyperplasia in routine gynecological practice
by: Ye. M. Poliakova, et al.
Published: (2019-02-01)